The New England Journal of Medicine
peer-reviewed medical journal
Positive
Negative
Entity sentiment
Reports
News
Opinions
Statements
Relations
science Nov 19, 2025, 11:02 PM
Pfizer's mRNA flu vaccine shows superior results in clinical trial - In a Phase 3 trial, over 18,000 adults received either Pfizer's mRNA flu vaccine or a standard flu shot during the 2022-2023 flu season.
- The mRNA vaccine showed approximately 27% higher efficacy than the traditional flu vaccine, although it also resulted in more side effects.
- These findings indicate the mRNA shot's potential as a new approach for influenza prevention.
100
2026 All rights reserved
2026 All rights reserved